Want to join the conversation?
$REGN said that there are currently a series of proposals from the centers for Medicare and Medicaid services regarding physician reimbursements. $REGN believes that this could lead to physicians using the company's competitors drugs bevacizumab or ranibizumab. The impact of any changes is difficult to predict, $REGN said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?